Medical Research News

RSS

Research reveals major drivers of increased nicotine and tobacco use during COVID-19 lockdown

Pandemic-related anxiety, boredom, and irregular routines were cited as major drivers of increased nicotine and tobacco use during the initial COVID-19 "lockdown," according to research just released by Columbia University's Mailman School of Public Health.

5 Mar 2021

Unstable initiation by young people to working life is linked with poorer mental health

A new study reveals that a precarious, unstable initiation by young people to working life is associated with poorer future mental health.

5 Mar 2021

Study highlights urgent need to monitor legal wildlife trade to reduce emerging zoonotic diseases

With three out of four newly emerging infectious human diseases originating in animals, there is an urgent need to monitor the legal trade in wildlife, according to new research by Vincent Nijman, Professor in Anthropology at Oxford Brookes University.

5 Mar 2021

Real-time fMRI neurofeedback offers a novel treatment method for psychiatric illness

In recent years, researchers have begun using functional magnetic resonance imaging (fMRI) not just for better understanding the neural bases of psychiatric illness, but also for experimental treatment of depression, ADHD, anxiety, PTSD, substance use disorder, and schizophrenia with a technique called real-time fMRI neurofeedback.

5 Mar 2021

Study reveals close link between Parkinson's disease and certain immune cells in the blood

Parkinson's disease has always been considered a brain disorder. However, new research reveals a close link between the disease and certain immune cells in the blood.

4 Mar 2021

COVID-19 lockdown has significantly increased loneliness, social issues among women

Social distancing guidelines have reduced the spread of COVID-19, but lockdowns and isolation also have created or aggravated other well-being concerns, reports new research.

4 Mar 2021

Failing to communicate COVID-19 vaccine uncertainties has negative consequences

All healthcare decisions come with uncertainty. In addition to the general risks that a healthcare professional is aware of, there is also uncertainty surrounding the associated probabilities, called ambiguity or radical uncertainties. These uncertainties grow as vaccines generated at an unprecedented pace are administered across the world.

4 Mar 2021

Preclinical study finds immune benefit in unrefrigerated Soligenix coronavirus vaccines

A new study reports positive outcomes from two new vaccine candidates. The research, led by Axel T. Lehrer from the University of Hawaii at Manoa, studied mice's immune response when administered the CoVaccine HT adjuvant with an insect-cell expressed SARS-CoV-2 spike protein ectodomain.

4 Mar 2021

Study explains how the B.1.1.7 SARS-CoV-2 variant is more transmissible

New research led by Thushan I. de Silva from the University of Sheffield proposes that increases in subgenomic RNA (sgRNA) expression cause increased viral transmissibility and subsequent infection. They suggest the ORF9 protein, found in high amounts of sgRNA, could be regulating interferon responses.

4 Mar 2021

Sounds, music linked to pleasant experiences can improve mood in people with memory problems

Hearing sounds that are linked to positive experiences from the past can considerably increase well-being, reduce depressive moods and alleviate behavioral problems in people with memory loss, a study by the University of Zurich in cooperation with clinical partners has found.

4 Mar 2021

Novavax COVID-19 vaccine shows efficacy against South African SARS-CoV-2 variant

Researchers in the United States and South Africa report that the NVX-CoV2373 vaccine from Novavax has proved effective at preventing coronavirus disease (COVID-19) caused by the B.1.351 variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has recently emerged in South Africa.

4 Mar 2021

New mRNA treatment appears to stop replication of flu and Covid-19 viruses

With a relatively minor genetic change, a new treatment developed by researchers at the Georgia Institute of Technology and Emory University appears to stop replication of both flu viruses and the virus that causes Covid-19.

4 Mar 2021

Brazilian SARS-CoV-2 P.1 variant shows resistance to antibody neutralization

Researchers in the United States say the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant – P.1 – that has recently emerged in Brazil shows a worrying level of resistance to neutralization by antibodies.

4 Mar 2021

Inflammatory heart disease is rare among professional athletes with mild COVID-19, study finds

Inflammatory heart disease is a rare finding among professional athletes with mild or asymptomatic COVID-19 infection, a large-scale study has found.

4 Mar 2021

New research project to explore the impact of urban lighting on health and wellbeing

While EU cities have worked on improving urban lighting services, this has mostly focussed on efficiency, reducing costs and lowering emissions.

4 Mar 2021

Combining terpenes and cannabidiol may be highly active against human coronaviruses

A group of researchers from a well-known technology company in Israel showed a significant antiviral effect of a combination of terpenes and cannabidiol against a human coronavirus strain 229E. This exciting and first-of-its-kind report is currently available on the bioRxiv preprint server.

4 Mar 2021

Experimental safety switch reduces severity of CAR-T immunotherapy-related side effects

UNC Lineberger Comprehensive Cancer Center researchers have successfully used an experimental safety switch, incorporated as part of a chimeric antigen receptor T-cell (CAR-T) therapy, a type of immunotherapy, to reduce the severity of treatment side effects that sometimes occur.

4 Mar 2021

Smoking cessation drug shows potential to treat Parkinson's disease in females

Texas A&M University College of Medicine ressearchers have recently discovered that cytisine -- a smoking cessation drug commonly used in Europe -- reduces the loss of dopamine neurons in females. These findings provide potential evidence for the use of the drug to treat Parkinson's disease or stop its progression in women.

4 Mar 2021

Study identifies potential therapeutic target for non-alcoholic fatty liver disease

An international team of researchers has identified the CNNM4 protein as a key regulator of magnesium in the liver and potential therapeutic target for non-alcoholic fatty liver disease, according to a study published in the Journal of Hepatology.

4 Mar 2021

Psychiatric and cognitive problems in large number of COVID-19 survivors

A research review led by Oxford Brookes University has found a large proportion of COVID-19 survivors will be affected by neuropsychiatric and cognitive complications.

4 Mar 2021

Medical Research News

Research reveals major drivers of increased nicotine and tobacco use during COVID-19 lockdown

Unstable initiation by young people to working life is linked with poorer mental health

Study highlights urgent need to monitor legal wildlife trade to reduce emerging zoonotic diseases

Real-time fMRI neurofeedback offers a novel treatment method for psychiatric illness

Study reveals close link between Parkinson's disease and certain immune cells in the blood

COVID-19 lockdown has significantly increased loneliness, social issues among women

Failing to communicate COVID-19 vaccine uncertainties has negative consequences

Preclinical study finds immune benefit in unrefrigerated Soligenix coronavirus vaccines

Study explains how the B.1.1.7 SARS-CoV-2 variant is more transmissible

Sounds, music linked to pleasant experiences can improve mood in people with memory problems

Novavax COVID-19 vaccine shows efficacy against South African SARS-CoV-2 variant

New mRNA treatment appears to stop replication of flu and Covid-19 viruses

Brazilian SARS-CoV-2 P.1 variant shows resistance to antibody neutralization

Inflammatory heart disease is rare among professional athletes with mild COVID-19, study finds

New research project to explore the impact of urban lighting on health and wellbeing

Combining terpenes and cannabidiol may be highly active against human coronaviruses

Experimental safety switch reduces severity of CAR-T immunotherapy-related side effects

Smoking cessation drug shows potential to treat Parkinson's disease in females

Study identifies potential therapeutic target for non-alcoholic fatty liver disease

Psychiatric and cognitive problems in large number of COVID-19 survivors

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Membrane proteins in focus: Turning high-risk targets into routine workflows

Latest News